A Novel Coronavirus 19 (COVID-19) Treatment Study
novel coronavirus (covid-19) study needing participants who live with someone who has covid-19

Are you vaccinated against COVID-19?

Are you or a loved one healthy and at least 50 years of age? Have you already had 2 doses of the Moderna COVID-19 vaccine (mRNA-1273)? If so, please consider this research study.

Get Started

Study Overview

Researchers will use this clinical study (V110-911) to learn about the safety and effects of giving a pneumococcal vaccination and COVID-19 booster vaccination at the same visit. This clinical study will help researchers learn:

What requirements are in place to help protect clinical study participants?

There are rules in place to help protect the rights, safety, and well-being of people who volunteer for research studies. These rules are put in place to make sure studies follow strict scientific and ethical guidelines. Before a clinical research study can begin, a review board must review the study. This group is called an IRB or institutional review board. An IRB is made up of doctors, scientists, and members of the community.

Who Can Join?

To participate in the V110-911 study, you must be 50 years or older and:

There are other rules for taking part that the study staff will discuss with you.

Get Started

What will happen if you take part?

Screening Period

(About 1 Day)

To ensure participants qualify, you will:

  • Have Physical and Medical Exams
  • Talk about your medical history

Vaccination and Follow-up Period

(About 6 Months)

If you qualify and agree to take part, you will have:

  • 3 in-person visits to the research clinic
  • 3 phone calls with research staff
  • A booster dose of the Moderna COVID-19 vaccine at the first visit. A pneumococcal vaccine or placebo will also be given
  • About a month later, you will receive a pneumococcal vaccine or placebo (whichever you didn’t get at the first visit)

During the study, tests and exams are also done to closely monitor participants. This may include:

  • Health history
  • Physical exams
  • Blood samples
  • Participants keeping an electronic diary of their health after vaccination

You will have a scheduled phone call 4 months after to:

  • Complete a questionaire over the telephone with the site staff to collect additional information since your first clinic visit

Why participate in this study?

A clinical study is a research study that tries to answer questions about how medicines or vaccines work in the people who take them. Researchers run studies to test whether an investigational medication or vaccine is safe and effective. These studies may help doctors find new ways to help prevent, detect, or treat health problems. Information learned from this clinical research study may help other people in the future. Those participating will receive the following:

  • Study-Related Care
  • Study vaccines including a COVID-19 booster and a pneumococcal vaccine

Is this mandatory?
Will it cost anything?

Taking part in this study is voluntary and you may stop at any time for any reason. In addition, there is no cost to participants or their insurance for the study drug or study-related care, tests and exams. Reimbursement for time and travel may be provided.

To see a list of locations

If you would like to see if you are eligible to participate, please find a site near you.

Find A Site Near You

Where can I learn more?

If you're interested in learning more about the V110-911 study, including potential risks and benefits of participation, you can find additional details at CTGOV.